المؤلفون: Cohen JA; Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy jcoen781@gmail.com., Rossi FM; Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy., Zucchetto A; Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy., Bomben R; Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy., Terzi-di-Bergamo L; Institute of Oncology Research, Bellinzona, Switzerland., Rabe KG; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA., Degan M; Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy., Steffan A; Immunopathology and Cancer Biomarkers, Centro di RiferimentoOncologico, I.R.C.C.S., Aviano (PN), Italy., Polesel J; Unit of Cancer Epidemiology, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy., Santinelli E; Division of Haematology, S. Eugenio Hospital and University of Tor Vergata, Rome, Italy., Innocenti I; Hematology Institute, Catholic University of the Sacred Heart, Fondazione Policlinico A. Gemelli, Rome, Italy., Cutrona G; UO Molecular Pathology, Ospedale Policlinico San Martino IRCCS, Genova, Italy., D'Arena G; Onco-Haematology Department, Centro di Riferimento Oncologico della Basilicata, I.R.C.C.S., Rionero in Vulture, Italy., Pozzato G; Department of Internal Medicine and Haematology, Maggiore General Hospital, University of Trieste, Trieste, Italy., Zaja F; Department of Internal Medicine and Haematology, Maggiore General Hospital, University of Trieste, Trieste, Italy., Chiarenza A; Division of Haematology, Ferrarotto Hospital, Catania, Italy., Rossi D; Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Universita' della Svizzera Italiana, Lugano, Switzerland., Di Raimondo F; Division of Haematology, Ferrarotto Hospital, Catania, Italy., Laurenti L; Hematology Institute, Catholic University of the Sacred Heart, Fondazione Policlinico A. Gemelli, Rome, Italy., Gentile M; Hematology Unit, AO, Cosenza, Italy.; Biotechnology Research Unit, Aprigliano, Cosenza, Italy., Morabito F; Biotechnology Research Unit, Aprigliano, Cosenza, Italy.; Hematogy Department and Bone Marrow Transplant Unit, Cancer Care Center, Augusta Victoria Hospital, East Jerusalem, Israel., Neri A; Hematology Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico and University of Milan, Milan, Italy., Ferrarini M; Department of Experimental Medicine, University of Genova, Genova, Italy., Fegan CD; Division of Cancer and Genetics, Cardiff University, School of Medicine, Heath Park, Cardiff, UK., Pepper CJ; Division of Cancer and Genetics, Cardiff University, School of Medicine, Heath Park, Cardiff, UK.; University of Sussex, Brighton and Sussex Medical School, Brighton, UK., Del Poeta G; Division of Haematology, S. Eugenio Hospital and University of Tor Vergata, Rome, Italy., Parikh SA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Kay NE; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Gattei V; Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy vgattei@cro.it.

المصدر: Haematologica [Haematologica] 2020 Jun; Vol. 105 (6), pp. 1613-1620. Date of Electronic Publication: 2019 Oct 03.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Lymphocytic, Chronic, B-Cell*/diagnosis , Leukemia, Lymphocytic, Chronic, B-Cell*/genetics , Leukemia, Lymphocytic, Chronic, B-Cell*/therapy, Humans ; Italy ; Laboratories ; Mutation ; Prognosis ; United Kingdom